Related Experiment Video
Updated: Sep 8, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Outcomes from a tertiary care center using a catheter thrombectomy system for managing acute iliofemoral deep vein
Michael A Jolly1, Marie M Lockhart2, Deep Shah3
1Interventional Cardiology and Vascular Medicine, Riverside Methodist Hospital, OhioHealth Heart and Vascular, Columbus, OH.
Insights
The ClotTriever system effectively removed acute iliofemoral deep vein thrombosis (DVT) in 97% of patients. This thrombectomy approach demonstrated safety and efficacy, even for patients with contraindications to thrombolysis.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Cardiovascular Medicine
Background:
- Acute iliofemoral deep vein thrombosis (IF-DVT) presents treatment challenges, particularly regarding complete thrombus removal and bleeding risks associated with thrombolysis.
- Existing endovascular devices often struggle with complete clot clearance, necessitating adjunctive therapies like thrombolysis.
Purpose of the Study:
- To evaluate the safety and efficacy of the ClotTriever thrombectomy system in a large, single-center cohort of patients with acute IF-DVT.
- To assess the system's performance in patients with contraindications to thrombolytic therapy.
Main Methods:
- A retrospective review of 96 consecutive patients with acute IF-DVT treated with the ClotTriever system.
- Efficacy assessed by independent core imaging laboratory; safety evaluated during index hospitalization.
- Vein patency assessed via duplex ultrasound at 30 days post-procedure.
Main Results:
- 97% of patients achieved ≥75% thrombus removal.
- No mortality, major bleeding, or device-related complications were reported.
- At 30 days, 97% of assessed patients showed normal flow and 83% normal compressibility.
Conclusions:
- The ClotTriever thrombectomy catheter is a safe and effective treatment option for acute IF-DVT.
- The system offers a viable alternative for patients unsuitable for thrombolytic therapy.
- Real-world data supports the use of ClotTriever in managing acute iliofemoral deep vein thrombosis.
Objective:
The aim of the present study was to report a large, single-center experience using the ClotTriever thrombectomy system (Inari Medical, Irvine, CA) for the management of acute iliofemoral (IF) deep vein thrombosis (DVT). One limitation of all endovascular devices for the treatment of acute IF-DVT has been the inability to completely remove all acute thrombus and the need for adjunctive thrombolysis with its attendant risk of bleeding complications.
Methods:
A single-center retrospective review of consecutive patients with acute IF-DVT treated with the ClotTriever thrombectomy system (Inari Medical) is reported. Procedural efficacy was evaluated by an independent core imaging laboratory (Syntactx, New York, NY). Both procedural and in-hospital safety were assessed during the index hospitalization. The treated vein patency was assessed using duplex ultrasound at 30 days after the procedure.
Results:
A total of 96 patients were included in the present retrospective review, 40 of whom (40%) had contraindications to thrombolytic therapy. In terms of efficacy, 93 patients (97%) had ≥75% thrombus removal. During the index hospitalization, two patients (2%) had experienced a symptomatic pulmonary embolus. However, no mortality, major bleeding, or device-related complications had occurred in the study population. Of the 96 patients, 64 had undergone duplex ultrasound at 30 days after the procedure. Of the 64 patients, 62 had normal flow (97%), 53 (83%) had normal compressibility, and 11 (17%) had partial compressibility.
Conclusions:
The ClotTriever thrombectomy catheter was both safe and effective in our cohort of patients with acute IF-DVT outside a randomized clinical trial.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care

